Neuromodulation Platform (Lead Program)
Chronic Disease (Cardiac/Neurological/Pain)
Key Facts
About iVEAcare
iVEAcare is a San Francisco-based digital health and medical device company founded in 2018, specializing in neuromodulation therapies for chronic conditions. The company is in the pre-clinical or early clinical stage, leveraging a leadership team with deep expertise in active implantable devices from companies like Boston Scientific, Medtronic, and Guidant. Backed by venture capital, iVEAcare aims to translate its founders' proven experience in developing and securing regulatory approval for Class III devices into novel treatments for burdensome chronic diseases. Its initial focus appears to be on cardiac and neurological applications, building on the team's prior successes with devices for heart failure, pain, and other conditions.
View full company profile